Free Trial

Anavex Life Sciences (AVXL) Earnings Date, Estimates & Call Transcripts

Anavex Life Sciences logo
$6.84
+0.21 (+3.17%)
(As of 11/1/2024 ET)

Anavex Life Sciences Latest Earnings Summary

Upcoming Q4
Earnings Date
Nov. 25Estimated
Actual EPS
(Aug. 6)
-$0.14 Beat By $0.01
Consensus EPS
(Aug. 6)
-$0.15

Anavex Life Sciences issued Q3 2024 earnings on August 6, 2024, reporting an EPS of -$0.14, which topped analysts' consensus estimates of -$0.15 by $0.01. With a trailing EPS of -$0.50, Anavex Life Sciences' earnings are expected to decrease next year, from ($0.55) to ($0.80) per share.

AVXL Upcoming Earnings

Anavex Life Sciences' next earnings date is estimated for Monday, November 25, 2024, based off prior year's reporting schedules.

Get Anavex Life Sciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Anavex Life Sciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

AVXL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AVXL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Anavex Life Sciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.15-$0.15-$0.15
Q2 20241-$0.13-$0.13-$0.13
Q3 20241-$0.15-$0.15-$0.15
Q4 20241-$0.18-$0.18-$0.18
FY 20244-$0.61-$0.61-$0.61
Q1 20251-$0.19-$0.19-$0.19
Q2 20251-$0.20-$0.20-$0.20
Q3 20251-$0.23-$0.23-$0.23
Q4 20251-$0.18-$0.18-$0.18
FY 20254($0.80)($0.80)($0.80)

Anavex Life Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/25/2024
(Estimated)
------- 
8/6/2024Q3 2024-$0.15-$0.14+$0.01-$0.14--  
5/9/2024Q2 2024-$0.13-$0.13--$0.13--      
2/7/2024Q1 2024-$0.15-$0.11+$0.04-$0.11--  
11/27/2023Q3 2023-$0.16-$0.12+$0.04-$0.12--      
8/8/2023Q3 2023-$0.17-$0.14+$0.03-$0.14--  
5/9/2023Q2 2023-$0.18-$0.17+$0.01-$0.17--      
2/7/2023Q1 2023-$0.20-$0.17+$0.03-$0.17--  
11/28/2022Q4 2022-$0.16-$0.18 -$0.02-$0.18--  

Anavex Life Sciences Earnings - Frequently Asked Questions

Anavex Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 25th, 2024 based off last year's report dates. Learn more on AVXL's earnings history.

In the previous quarter, Anavex Life Sciences (NASDAQ:AVXL) reported ($0.14) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.15) by $0.01. Learn more on analysts' earnings estimate vs. AVXL's actual earnings.

Anavex Life Sciences (NASDAQ:AVXL) has a recorded net income of -$47.51 million. AVXL has generated -$0.50 earnings per share over the last four quarters.

Anavex Life Sciences's earnings are expected to decrease from ($0.55) per share to ($0.80) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:AVXL) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners